In this study, we showed that USP46 expression is downregulated in patients with lung cancer, suggesting a tumor suppressor role of USP46 in lung cancer, which is consistent with the reports from other studies in colorectal cancer [9] and renal cell carcinoma [13]. This evidence concerns the gene USP46 and renal cell carcinoma.